Promega Corporation Viafect™ Transfection Reagent Delivers High Performance Transfection Across Multiple Cell Lines, Including iPS Cells

MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation announces ViaFect™ Transfection Reagent, a tool for efficient DNA transfer into a wide variety of cell lines, including challenging suspension cells and stem cell-derived lines. ViaFect Transfection Reagent allows researchers to develop transfection-based assays in the cell line most relevant for their biology of interest.

Help employers find you! Check out all the jobs and post your resume.